Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Implantable Device Carve-Outs From HCFA Outpatient PPS Proposed By HIMA

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration should "carve out" all implantable devices from its proposed prospective payment system (PPS) for outpatient hospital departments, the Health Industry Manufacturers Association suggests in July 28 comments.

You may also be interested in...



Senate Medicare Coverage Bill Restricts HCFA Outpatient PPS Proposal

The Health Care Financing Administration would be required to use average rather than median costs in setting payment weights for medical devices reimbursed on an outpatient basis, under legislation introduced Sept. 23 by Sen. Orrin Hatch (R-Utah).

Senate Medicare Coverage Bill Restricts HCFA Outpatient PPS Proposal

The Health Care Financing Administration would be required to use average rather than median costs in setting payment weights for medical devices reimbursed on an outpatient basis, under legislation introduced Sept. 23 by Sen. Orrin Hatch (R-Utah).

Outpatient PPS Rule Sparks Concern Over Cyberonics' NCP, Radiosurgery

At least nine hospitals are requesting an increase in the Medicare reimbursement rate for Cyberonics' NCP neurocybernetic prosthesis by the Health Care Financing Administration.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel